Idiopathic Hypersomnia
Symptoms, Doctors, Treatments, Advances & More

Idiopathic Hypersomnia Overview

Save information for later
Sign Up

Learn About Idiopathic Hypersomnia

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Idiopathic Hypersomnia Local Doctors?
Elite in Idiopathic Hypersomnia
Sleep Medicine
Elite in Idiopathic Hypersomnia
Sleep Medicine

Emory Sleep Center

12 Executive Park Drive Northeast, 
Atlanta, GA 
Experience:
23+ years
Languages Spoken:
English
Offers Telehealth

Lynn Trotti is a Sleep Medicine provider practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 23 years. Dr. Trotti is rated as an Elite provider by MediFind in the treatment of Idiopathic Hypersomnia. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Idiopathic Hypersomnia, Drowsiness, Excessive Daytime Sleepiness, Restless Legs Syndrome, and Hormone Replacement Therapy (HRT). Dr. Trotti is board certified in American Board Of Psychiatry And Neurology, 2009.

Elite in Idiopathic Hypersomnia
Elite in Idiopathic Hypersomnia

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
Experience:
42+ years
Languages Spoken:
English
Offers Telehealth

Nancy Foldvary is a Neurologist practicing medicine in Cleveland, Ohio. She has been practicing medicine for over 42 years. Dr. Foldvary is rated as an Elite provider by MediFind in the treatment of Idiopathic Hypersomnia. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Narcolepsy, Drowsiness, Obstructive Sleep Apnea, and Idiopathic Hypersomnia. Dr. Foldvary is board certified in American Board Of Psychiatry And Neurology, 2013.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Idiopathic Hypersomnia
Sleep Medicine | Pediatric Neurology
Elite in Idiopathic Hypersomnia
Sleep Medicine | Pediatric Neurology

Geisinger Medical Center - Pediatric Neurology

100 North Academy Avenue, 
Danville, PA 
Languages Spoken:
English

Dr. Morse is a board-certified and fellowship-trained pediatric neurologist. Her clinical interests include sleep-wake disorders in neurologic disease, narcolepsy and hypersomnia disorders and neuroimmunology. Her research interests include sleep-wake disorders in neurologic disease, hypersomnia disorders and sleep-wake disorder phenotyping. Dr. Morse earned her degree in osteopathy from Rowan University. She completed her residency and her child neurology fellowship at the State University of New York, Downstate Medical Center. She completed another fellowship in sleep medicine at the Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center. Dr. Morse is certified by the American Board of Psychiatry and Neurology in neurology with special qualification in child neurology.|Video: more from Dr. Anne Morse, M.D. Dr. Morse is rated as an Elite provider by MediFind in the treatment of Idiopathic Hypersomnia. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Narcolepsy, Excessive Daytime Sleepiness, Idiopathic Hypersomnia, and Sleep Paralysis. Dr. Morse is board certified in The American Board Of Psychiatry And Neurology In Neurology With Special Qualification In Child Neurology.

What are the latest Idiopathic Hypersomnia Clinical Trials?
A Phase 2, Long-term Extension Study of the Safety and Efficacy of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia Who Completed a Sponsored ORX750 Clinical Trial

Summary: This study is a long-term extension (LTE) of the parent Study ORX750 0201, and will provide long-term open-label safety, tolerability, and efficacy of ORX750 in participants with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH).

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) Followed by an Open-label Extension

Summary: This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-301 in treating idiopathic hypersomnia (IH) symptoms, including excessive daytime sleepiness (EDS), sleep inertia, and fatigue in adult participants (ages ≥18 years) with idiopathic hypersomnia (IH). The primary objective of this study is to evaluate ...